h2rose
07-15
m吗1444月
燃石医学盘中异动 股价大跌5.86%报3.21美元
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":456831735857480,"tweetId":"456831735857480","gmtCreate":1752567870102,"gmtModify":1752569635267,"author":{"id":3504737762783443,"idStr":"3504737762783443","authorId":3504737762783443,"authorIdStr":"3504737762783443","name":"h2rose","avatar":"https://static.tigerbbs.com/a88dd83eef835d3b85a437f21c5399b9","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.01","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>m吗1444月</p></body></html>","htmlText":"<html><head></head><body><p>m吗1444月</p></body></html>","text":"m吗1444月","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/456831735857480","repostId":2546742937,"repostType":2,"repost":{"id":"2546742937","kind":"news","pubTimestamp":1751033194,"share":"https://www.laohu8.com/m/news/2546742937?lang=&edition=full","pubTime":"2025-06-27 22:06","market":"us","language":"zh","title":"燃石医学盘中异动 股价大跌5.86%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546742937","media":"市场透视","summary":"北京时间2025年06月27日22时06分，燃石医学股票出现异动，股价急速下跌5.86%。截至发稿，该股报3.21美元/股，成交量8303股，换手率0.08%，振幅5.57%。燃石医学股票所在的生命科学行业中，整体涨幅为0.38%。其相关个股中，Applied Dna Sciences, Inc.、Prophase Labs, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 涨幅较大，Bioaffinity Technologies, Inc.、Applied Dna Sciences, Inc.、Advanced Biomed Inc.较为活跃，换手率分别为13.09%、3.32%、1.37%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 、Prenetics Global，振幅分别为15.28%、13.30%、8.57%。其大部分收入来自中心实验室业务。","content":"<html><body><article><p>北京时间2025年06月27日22时06分，<a href=\"https://laohu8.com/S/BNR\">燃石医学</a>（BNR.us）股票出现异动，股价急速下跌5.86%。截至发稿，该股报3.21美元/股，成交量8303股，<span>换手率</span>0.08%，振幅5.57%。</p><p>最近的财报数据显示，该股实现<span>营业收入</span>18.29百万美元，<span>净利润</span>-1.86百万美元，<span>每股收益</span>-0.17美元，<span>毛利</span>13.39百万美元，市盈率-1.02倍。</p><p>机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。</p><p>燃石医学股票所在的生命科学行业中，整体涨幅为0.38%。其相关个股中，Applied Dna Sciences, Inc.、Prophase Labs, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 (To Pur Com)涨幅较大，Bioaffinity Technologies, Inc.、Applied Dna Sciences, Inc.、<a href=\"https://laohu8.com/S/ADVB\">Advanced Biomed</a> Inc.较为活跃，换手率分别为13.09%、3.32%、1.37%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 (To Pur Com)、<a href=\"https://laohu8.com/S/PRE\">Prenetics Global</a>，振幅分别为15.28%、13.30%、8.57%。</p><p>燃石医学公司简介：燃石医学有限公司是一家癌症诊断公司。它是一家基于 NGS 的癌症疗法选择公司。癌症疗法选择平台建立在先进的专有技术，全面的产品组合和双管齐下的市场驱动型商业基础设施之上，通过院内模式服务于大型医院，通过中心实验室模式服务于小型医院。该公司有三个运营分部，包括中心实验室业务，院内业务和医药研发服务。其大部分收入来自中心实验室业务。其产品包括 Pan-HEME，OncoScreen-WES，brPROPHET，OncoScreen Plus 等。</p><p>（以上内容为<a href=\"https://laohu8.com/S/00700\">腾讯</a>自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>燃石医学盘中异动 股价大跌5.86%报3.21美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n燃石医学盘中异动 股价大跌5.86%报3.21美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-27 22:06 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062722063497917a6b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年06月27日22时06分，燃石医学（BNR.us）股票出现异动，股价急速下跌5.86%。截至发稿，该股报3.21美元/股，成交量8303股，换手率0.08%，振幅5.57%。最近的财报数据显示，该股实现营业收入18.29百万美元，净利润-1.86百万美元，每股收益-0.17美元，毛利13.39百万美元，市盈率-1.02倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062722063497917a6b&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNR":"燃石医学","BK4139":"生物科技"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062722063497917a6b&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2546742937","content_text":"北京时间2025年06月27日22时06分，燃石医学（BNR.us）股票出现异动，股价急速下跌5.86%。截至发稿，该股报3.21美元/股，成交量8303股，换手率0.08%，振幅5.57%。最近的财报数据显示，该股实现营业收入18.29百万美元，净利润-1.86百万美元，每股收益-0.17美元，毛利13.39百万美元，市盈率-1.02倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。燃石医学股票所在的生命科学行业中，整体涨幅为0.38%。其相关个股中，Applied Dna Sciences, Inc.、Prophase Labs, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 (To Pur Com)涨幅较大，Bioaffinity Technologies, Inc.、Applied Dna Sciences, Inc.、Advanced Biomed Inc.较为活跃，换手率分别为13.09%、3.32%、1.37%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 (To Pur Com)、Prenetics Global，振幅分别为15.28%、13.30%、8.57%。燃石医学公司简介：燃石医学有限公司是一家癌症诊断公司。它是一家基于 NGS 的癌症疗法选择公司。癌症疗法选择平台建立在先进的专有技术，全面的产品组合和双管齐下的市场驱动型商业基础设施之上，通过院内模式服务于大型医院，通过中心实验室模式服务于小型医院。该公司有三个运营分部，包括中心实验室业务，院内业务和医药研发服务。其大部分收入来自中心实验室业务。其产品包括 Pan-HEME，OncoScreen-WES，brPROPHET，OncoScreen Plus 等。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","news_type":1,"symbols_score_info":{"BNR":1}},"isVote":1,"tweetType":1,"viewCount":479,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":9,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/456831735857480"}
精彩评论